ArticlePloS one2017

Monitoring tumor response to neoadjuvant chemotherapy using MRI and 18F-FDG PET/CT in breast cancer subtypes.

Alexander M Th Schmitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.